Emily Hajjar

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentJSP - Pharmacy Practice
Address130 S. 9th Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hanlon JT, Hajjar ER. Isn't It Time We Stop Counting the Number of Drugs to Define Polypharmacy in This New Era of Deprescribing and What Related Outcomes Should Be Measured? J Am Med Dir Assoc. 2018 May 31. PMID: 29861195.
      Citations:    
    2. Hersh LR, Beldowski K, Hajjar ER. Polypharmacy in the Geriatric Oncology Population. Curr Oncol Rep. 2017 Sep 23; 19(11):73. PMID: 28942563.
      Citations:    
    3. McGrath K, Hajjar ER, Kumar C, Hwang C, Salzman B. Deprescribing: A simple method for reducing polypharmacy. J Fam Pract. 2017 Jul; 66(7):436-445. PMID: 28700758.
      Citations:    
    4. Nightingale G, Hajjar E, Pizzi LT, Wang M, Pigott E, Doherty S, Prioli KM, Swartz K, Chapman AE. Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer. J Geriatr Oncol. 2017 Jul; 8(4):296-302. PMID: 28506543.
      Citations:    
    5. Leon N, Hajjar E, DeSevo Bellottie G. Sequencing of Simulation and Clinic Experiences in an Introductory Pharmacy Practice Experience. Am J Pharm Educ. 2015 Oct 25; 79(8):120. PMID: 26688585.
      Citations:    
    6. Nightingale G, Hajjar E, Guo K, Komura S, Urnoski E, Sendecki J, Swartz K, Chapman A. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer. J Geriatr Oncol. 2015 Sep; 6(5):411-7. PMID: 26277113.
      Citations:    
    7. Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015 May 1; 33(13):1453-9. PMID: 25800766.
      Citations:    
    8. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014 Jan; 13(1):57-65. PMID: 24073682.
      Citations:    
    9. Salzman B, Collins L, Hajjar ER. Chronic disease management: the changing landscape of primary care. Prim Care. 2012 Jun; 39(2):xv-xxi. PMID: 22608877.
      Citations:    
    10. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012 May; 28(2):173-86. PMID: 22500537.
      Citations:    
    11. Rossi MI, Young A, Maher R, Rodriguez KL, Appelt CJ, Perera S, Hajjar ER, Hanlon JT. Polypharmacy and health beliefs in older outpatients. Am J Geriatr Pharmacother. 2007 Dec; 5(4):317-23. PMID: 18179989.
      Citations:    
    12. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007 Dec; 5(4):345-51. PMID: 18179993.
      Citations:    
    13. Lindblad CI, Hanlon JT, Gross CR, Sloane RJ, Pieper CF, Hajjar ER, Ruby CM, Schmader KE. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther. 2006 Aug; 28(8):1133-43. PMID: 16982290.
      Citations:    
    14. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, Schmader KE. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci. 2006 May; 61(5):511-5. PMID: 16720750.
      Citations:    
    15. Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, Branch LC, Schmader KE. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005 Sep; 53(9):1518-23. PMID: 16137281.
      Citations:    
    16. Lindblad CI, Artz MB, Pieper CF, Sloane RJ, Hajjar ER, Ruby CM, Schmader KE, Hanlon JT. Potential drug-disease interactions in frail, hospitalized elderly veterans. Ann Pharmacother. 2005 Mar; 39(3):412-7. PMID: 15687479.
      Citations:    
    17. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, Ruby CM, Schmader KE. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003 Dec; 1(2):82-9. PMID: 15555470.
      Citations:    
    18. Hanlon JT, Lindblad CI, Hajjar ER, McCarthy TC. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother. 2003 Sep; 1(1):38-43. PMID: 15555464.
      Citations:    
    Hajjar's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (69)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _